IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Anthem Biosciences

NSE:ANTHEM · ISIN INE0CZ201020

Close
₹790
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Anthem Biosciences

Ratings & risks

Credit signals

Rating-action history

Agency evidence
ICRA Limited · Anthem Biosciences Limited: Long-term rating upgraded to[ICRA]AA (Stable) from [ICRA]AA- (Positive); outlook revised to Stable from Positive; short-term rating reaffirmed; assigned for enhanced amountICRA Limited · PDF preserved by IndiaTicker
Archived PDF
ICRA Limited · Anthem Biosciences Limited: Ratings reaffirmed and assigned; rated amount enhanced; outlook revised to Positive from StableICRA Limited · discovered
Agency source
ICRA Limited · Anthem Biosciences Pvt. Ltd.: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Anthem Biosciences Pvt. Ltd.: Ratings reaffirmed; rated amount enhancedICRA Limited · discovered
Agency source
ICRA Limited · Anthem Biosciences Pvt. Ltd.: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Anthem Biosciences Pvt. Ltd.: Ratings upgraded to [ICRA]AA- (Stable)/[ICRA]A1+ICRA Limited · discovered
Agency source
ICRA Limited · Anthem Biosciences Pvt. Ltd.: Ratings upgraded to [ICRA]A (Stable)/[ICRA]A1ICRA Limited · discovered
Agency source
ICRA Limited · Anthem Biosciences Pvt. Ltd.: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Anthem Biosciences Pvt. Ltd.: Ratings reaffirmed, rated amount enhancedICRA Limited · discovered
Agency source
ICRA Limited · ICRA upgrades ratings for bank loans of Anthem Biosciences Private Limited To [ICRA]A- (Stable) / [ICRA]A2 from [ICRA]BBB (Stable) [ICRA]A3+ICRA Limited · discovered
Agency source
Risk research framework

Questions to test against evidence

Analyst review
Operating deterioration

Track sector-specific operating metrics and reconcile them across reporting periods.

High
Funding and liquidity

Review debt maturity, repricing, liquidity and rating commentary where relevant.

High
Execution versus guidance

Compare management statements with subsequent reported delivery.

Medium
Governance and key-person change

Connect management transitions, related parties and auditor observations.

Medium